Skip to main content
The Evening Leader?
Place a Classified Ad
Classified Display Ads
Treasury & Bonds
View Full List
Dow Jones Industrial Average
Standard & Poors 500
New York Composite
Streaming Delayed Price
8:54 AM EDT, Sep 20, 2018
Add to My Watchlist
Price and Volume
3158.03 - 3173.28
2607.92 - 3358.68
Seattle Genetics Inc
Amgen And Los Angeles County Announce Collaboration To Support Life Science Innovation Hub - BioLA
Today 9:00 EDT
Amgen's David Piacquad to Join BioLA Board of Directors
SevenSaoi Capital Delivers Letter to the Board of PDL BioPharma
Today 8:30 EDT
Expresses Serious Concerns Regarding PDL's Misguided Acquisition Strategy, Which Has Destroyed Shareholder Value
As Genome Sequencing Reaches A Tipping Point, These Stocks Climb
Today 8:00 EDT
Genome sequencing is enabling biotech and pharmaceutical firms to discover new ways to target diseases tied to the human genome.
Investor's Business Daily
How The Parts Add Up: IJK Headed For $257
Today 7:12 EDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
Today 6:00 EDT
Amicus Therapeutics (Nasdaq: FOLD) today announced the signing of a definitive agreement in which Amicus Therapeutics will receive worldwide development and commercial rights for ten gene therapy...
GlobeNewswire News Releases
UPDATE 1-EU approves fifth copy of AbbVie's $18 bln drug Humira
Today 5:02 EDT
* European Humira sales around $4.4 bln a year (Adds details on biosimilars market in Europe, graphic)
Reuters: Company News
Mylan, Fujifilm win EU okay for copy of AbbVie's Humira
Today 4:00 EDT
Mylan and Fujifilm Kyowa Kirin Biologics said on Thursday they had won European approval to market a cheaper copy of AbbVie's $18-billion-a-year biologic drug Humira, the world's best-selling...
Reuters: Company News
5 Stocks Primed To Fall Lower In The Coming Days
September 19, 2018
The following stocks are currently in the midst of various stages of downtrends according to VantagePoint, an AI charting platform that ...
Data & News supplied by
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Terms and Conditions
Request new password
Copyright © 2015 The Evening Leader | 102 E. Spring St. | St. Marys, OH 45885 | (419) 394-7414
All property rights for the entire contents of this publication shall be the property of The Evening Leader.
No part hereof may be reproduced without prior written consent.